Blood-based lipid biomarker panel for personalized risk assessment of breast …

Abstract

A novel 11-lipid biomarker panel, consisting of or comprising at least one ceramide, at least one sphingomyelin, at least one glycosphingolipid, and at least one free fatty acid, capable of assessing the risk of breast cancer is described.